AI drug discovery platform Insilico Medicine announces $255 million in Series C funding
Insilico Medicine, an AI-based platform for drug development and discovery, announced $255 million in Series C financing on Tuesday. The massive round is reflective of a recent breakthrough for the company: proof that its AI-based platform can create a new target for a disease, develop a bespoke molecule to address it and begin the clinical … Continue reading AI drug discovery platform Insilico Medicine announces $255 million in Series C funding
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed